The measure would prohibit prescription plans from charging copays in excess of the cash price of medications.

Having cleared the Senate in April, the measure, which authorizes physician assistants to sign Practitioner Orders for Life-Sustaining Treatment forms, heads next to Gov. Phil Murphy.

The joint company will focus on providing high-quality, convenient medical care across the New York/New Jersey metro area.

On June 18, pharmacies throughout the state gave out free doses of the opioid antagonist, which can reverse or block on overdose, as part of a program from the Department of Human Services.

Assembly Bill and Senate Bill 20, which the lower house approved by 66-5 vote with 6 abstentions and the upper house approved in a 31-5 vote, retains many provisions of the original medical marijuana legislation.

The expansion brings the company's overall footprint to 48 facilities.

Attorney General Gurbir Grewal and NJ CARES announced the funding, which will be dedicated to establishing and expanding the county-based programs wherein law enforcement officers proactively connect individuals suffering from opioid addiction with treatment and/or recovery support services.

The measure would restore funding for the Navigator outreach program which helps American families get information and support to find a health care plan at a price they can afford.

The report from Rutgers - according to the university, one of the largest genetic studies of Hispanics and Latinos, African-Americans, Asians and other minorities - can help to identify mutations that may cause debilitating diseases so that effective treatments can be developed.

According to the report's senior author, the topic is important because changes in patterns of gene expression in tumor cells play a key role in cancer development, its progression and therefore, its treatment.

The former co-chair of the Hackensack Meridian Health board of trustees and the founding chair of the board of governors of the Hackensack Meridian School of Medicine at Seton Hall University was a well-known figure in New Jersey business, government, health care and politics for more than four decades.

The facility will provide the Somerset-based company with access to an advanced sterile drug product fill/finish and packaging capacity in Europe, complementing its existing sterile fill/finish capabilities in Belgium and its drug substance, analytical and fill/finish capabilities in North America.